MINIMALLY INVASIVE SURGERIES IN BREAST CANCER: INTEGRATIVE REVIEW

Abstract

Breast cancer is a major public health issue and one of the leading causes of cancer-related mortality among women worldwide. In recent decades, surgical treatment has shifted from radical approaches to strategies that combine oncological effectiveness, functional preservation, and quality of life. This study aimed to analyze scientific evidence on minimally invasive surgeries for breast cancer treatment, focusing on oncological, perioperative, and quality-of-life outcomes. This integrative literature review was conducted using the PubMed, SciELO, and LILACS databases, including studies published between 2021 and 2026 according to PRISMA-ScR criteria. Thirteen articles were selected, including randomized clinical trials and observational studies, with a total sample of 14,053 patients. The results demonstrated that minimally invasive approaches, such as breast-conserving surgery, oncoplastic surgery, axillary surgery de-escalation, and ablative techniques, present oncological effectiveness equivalent to conventional surgeries, without compromising survival or disease control. In addition, these strategies reduced surgical morbidity and improved psychosocial and aesthetic outcomes. It is concluded that these approaches represent safe and effective alternatives.